Search results
Author(s):
Added:
5 months ago
Discover the rapidly evolving therapeutic options transforming outcomes for cardiac amyloidosis patients with Dr Sarah Cuddy.This comprehensive presentation, part of the Cardiomyopathies track, explores the dramatic advances in both TTR and AL amyloidosis treatment over the past decade. Dr Cuddy examines how modern therapeutic approaches have fundamentally shifted survival curves, particularly…
View more
Author(s):
Giorgia Panichella
,
Alberto Aimo
,
Vincenzo Castiglione
,
et al
Added:
7 months ago
Shakeel Qureshi
Job title: Consultant Paediatric Cardiologist
Author
Added:
1 month ago
Source:
Radcliffe Cardiology
A novel cardiac myosin agonist, danicamtiv, has shown favourable safety and efficacy signals in patients with dilated cardiomyopathy (DCM), particularly in those with specific genetic variants, according to results from a phase 2a open-label trial.¹ Precision therapies for DCM are currently lacking, despite its diverse clinical manifestations often linked to underlying genetic causes.²Danicamtiv…
View more
Author(s):
Pam Taub
,
Nikolaus Marx
Added:
1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical…
View more
Bill D Gogas
Job title: Editor-in-Chief, US Cardiology Review
Author
Overcoming the Challenges in Optimising GDMT in HF
Video Series
Michael S Firstenberg
Job title: Director of Research and Special Projects
Author
Author(s):
Angela Cozma
,
Violeta Briciu
,
Adela Viviana Sitar-Tăut
,
et al
Added:
10 months ago
